• About
  • Overview
  • Management
    • Dr. Joe Lewis
    • Dr. Bernd Janssen
    • Dr Fiona McLaughlin
    • Sally-Anne Watson
  • Supervisory Board
  • Scientific Advisory Board
  • Investors
• Programs
  • Mechanism of Action
  • Technology
  • Products
  • Technology Fact Sheet
• News
  • Latest News
  • Upcoming Events
  • Download Area
• Careers
  • Vacancies
• Contact
  • Contact
• Home
  • Home

Scientific Advisory Board

Prof. Frank Giles is Professor of Medicine and Chief of the Division of Hematology and Medical Oncology at the University of Texas Health Science Center, San Antonio and Director of the Institute of Drug Development (IDD) at the Cancer Therapy & Research Center and Director of the Experimental Therapeutics Program of the San Antonio Cancer Institute. He has authored over 400 peer-reviewed articles on research into developmental therapeutics for patients with cancer. Prior to this, Prof. Giles was Chief of the Section of Developmental Therapeutics at MD Anderson Cancer Center and Co-Chair of the Division of Cancer Medicine Phase I Group. His research focuses on the development of novel therapies for patients with cancer with a focus on targeted therapies. Prof. Giles received his Doctorate in Medicine from the National University of Ireland.